Oral

HPV vaccine could improve women’s health by sharply reducing cervical cancer rates, but achieving this requires broad uptake of the vaccine, especially among those at highest risk. In this session, we will present findings from the Carolina HPV Immunization Measurement and Evaluation (CHIME) Project, a multi-component evaluation of HPV vaccine use in areas with high cervical cancer rates. We start with micro-level issues related to measurement and finish with macro-level issues related to policy. Topics include proper measurement of the factors likely to affect HPV vaccine uptake, findings from the nation’s first longitudinal study of HPV vaccine uptake, groundbreaking data on HPV vaccine-related pain, and parents’ support for school-based requirements for HPV vaccination. The session is intended to be useful to behavioral scientists, practitioners, and policy makers.

Session Objectives: 1. Measure key parental beliefs about HPV vaccine; 2. Identify factors that influence HPV vaccine initiation that would be useful for developing interventions; 3. Describe whether pain associated with HPV vaccination is greater or less than pain from other adolescent vaccines; and 4. Describe parental support for school-based HPV vaccination requirements.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)